Developmental Biology: Embryogenesis, Organoids & Geroscience
UPSC Mains PYQs
- Developmental Technologies (2020): Discuss the clinical and socioeconomic significance of In-Vitro Fertilization (IVF) and prenatal screening technologies in India. Analyze the ethical concerns surrounding commercial surrogacy. (10 Marks, 150 Words)
📊 High-Yield Data & Statistical Fact Sheet
- Aging & Developmental Metrics:
- Elderly Boom: Elderly population (60+ years) projected to double from 10.4% in 2021 (149 Million) to 20.8% by 2050 (347 Million) (UNFPA India).
- Birth Defects: WHO states congenital defects account for 8-10% of neonatal deaths in India, with congenital heart defects most common (9 per 1,000 births).
- IVF Market: Indian Assisted Reproductive Technology (ART) market valued at $793 Million (scaling to $3.7 Billion by 2030), executing 2.5 to 3 Lakh IVF cycles annually.
- ART Act 2021: Regulates 3,000+ clinics, mandating donor logs for 10 years and limiting oocyte retrieval to 1 cycle per donor.
- Senolytic Efficacy: Target therapies removing senescent p16/p21 pathways extend model lifespans by 36% and lower frailty by 20%.
1. EMBRYOGENESIS, DIFFERENTIATION & ART REGULATORY MOAT
- Embryonic Development:
- Differentiation: The progressive cell-specialization cascade where pluripotent stem cells transition into lineage-restricted somatic tissues (muscles, nerves, bone).
- Morphogenesis: The biological process controlling cell spatial organization to form physical anatomical organs.
- Teratogens: Environmental toxins (drugs, pollutants, maternal infections) inducing physical birth defects during early embryogenesis.
- ART & Surrogacy Regulation Acts 2021:
- Assisted Reproductive Technology Act: Regulates IVF clinics, enforcing mandatory donor screening, prohibiting sex-selection, and requiring electronic donor record logs.
- Surrogacy (Regulation) Act: Bans commercial surrogacy, permitting only altruistic surrogacy for legally wed Indian couples and single women (divorced/widowed) under strict age thresholds.
2. REGENERATIVE MEDICINE & LAB-GROWN ORGANOIDS
- Organoid Technology: Growing miniature, 3D simplified versions of physical human organs (e.g., mini-brains, mini-kidneys, mini-livers) in-vitro from stem cells:
- Drug Discovery: Bypasses animal testing by providing high-fidelity human cellular structures to test drug toxicity and target efficacy.
- Pathogenesis Study: Enables real-time tracking of cellular reactions to viral infections (e.g., Zika, SARS-CoV-2) inside organ tissues.
- Regeneration (Epimorphosis): The complete physical replacement of complex lost limbs or damaged organs (naturally occurring in salamanders), which researchers seek to replicate using pluripotent scaffolding.
3. GEROSCIENCE, TELOMERES & SENESCENCE
- The Biology of Aging:
- Telomere Decay: Chromosome ends (protective caps called telomeres) lose 50-200 base pairs per cell division. Depletion triggers the Hayflick Limit (40-60 divisions), locking cells into senescence.
- Senescence (Zombie Cells): Damaged cells that cease dividing but refuse to undergo apoptosis. They secrete high-density inflammatory cytokines (SASP), driving systemic aging and tissue degradation.
- Geroscience & Senolytics: An emerging field targeting the biological engines of aging to extend human "health-span" (living disease-free) rather than merely chronological "life-span." Deploys senolytics (e.g., p16/p21 gene targeted drugs) to selectively destroy zombie cells.
QUICK REVISION BOX
- Pioneering Ageing Report: UNFPA India Ageing Report 2023.
- Statutory Surrogacy Model: Altruistic Surrogacy (Commercial banned).
- Miniature Lab-Grown Organs: Organoids.
- Chromosome Protective Caps: Telomeres.
- Cell Division Ceiling Limit: Hayflick Limit (40-60 divisions).
- Inflammatory Non-Dividing Cells: Senescent Cells ("zombie cells").
- Targeted Aging Extension: Geroscience (extends health-span).
Notes updated up to March 2026. Sources: UNFPA India Reports, Nature Medicine Longevity Reviews.